BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Net Change in Cash
BRAIN Biotech AG
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Net Change in Cash
-€6.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Net Change in Cash
€119m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-7%
|
|
Evonik Industries AG
XETRA:EVK
|
Net Change in Cash
€104m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
Covestro AG
XETRA:1COV
|
Net Change in Cash
-€573m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Net Change in Cash
€2.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Net Change in Cash
€78.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is BRAIN Biotech AG's Net Change in Cash?
Net Change in Cash
-6.2m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Net Change in Cash amounts to -6.2m EUR.
What is BRAIN Biotech AG's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
8%
Over the last year, the Net Change in Cash growth was 48%.